Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,166,821 papers from all fields of science
Search
Sign In
Create Free Account
T 3761
Known as:
T-3761
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
pazufloxacin
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
1999
1999
In vitro Activities of Pazufloxacin,a Novel In jectable Quinolone, against Bacteria Causing Infections in Obstetric and Gynecological Patients
H. Mikamo
,
Yasumasa Sato
,
Y. Hayasaki
,
K. Kawazoe
,
T. Tamaya
Chemotherapy
1999
Corpus ID: 44475996
T-3762 is an injectable new quinolone with a broad spectrum of antibacterial activity. Pazufloxacin (T-3761) is an active form of…
Expand
1995
1995
[Mechanism of renal excretion of T-3761, a novel fluoroquinolone agent, in rabbits].
Y. Fukuda
,
T. Muratani
,
+4 authors
H. Narita
The Japanese Journal of Antibiotics
1995
Corpus ID: 27141715
The mechanism of the renal excretion of T-3761, a novel oral fluoroquinolone agent, was studied by renal clearance, stop-flow…
Expand
1995
1995
[Studies on structure of light degradation products of (-)-(S)-10-(1-aminocyclopropyl)-9-fluoro-3-methyl-7-oxo-2,3-dihyd ro-7H- pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid (T-3761) in aqueous…
K. Demachi
,
H. Maeda
,
+6 authors
H. Narita
Yakugaku zasshi : Journal of the Pharmaceutical…
1995
Corpus ID: 33992996
The structures of light degradation products of (-)-(S)-10-(1-aminocyclopropyl)-9-fluoro-3-methyl-7-oxo-2,3-dih ydr o-7H- pyrido…
Expand
1995
1995
[Phototoxicity and photoallergenicity tests of T-3761].
T. Shibata
,
M. Nagasawa
,
N. Iwai
,
M. Miyazaki
,
Y. Kawamura
,
T. Kodama
The Japanese Journal of Antibiotics
1995
Corpus ID: 11353463
Phototoxicity and photoallergenicity tests of T-3761 (oral or percutaneous administration) were carried out in guinea pigs…
Expand
1995
1995
[Affinity of T-3761 to ocular melanin and intraocular dynamics].
H. Hayakawa
,
K. Hayashi
,
+4 authors
M. Oishi
The Japanese Journal of Antibiotics
1995
Corpus ID: 24512626
The affinity of T-3761 to melanin was examined with synthetic melanin comparing other quinolones. The binding rates with…
Expand
1995
1995
[Absorption, distribution, metabolism and excretion of T-3761, a new quinolone derivative, in experimental animals].
S. Minami
,
M. Takahata
,
+7 authors
J. Maehana
The Japanese Journal of Antibiotics
1995
Corpus ID: 27064372
We studied the absorption, distribution, metabolism and excretion of T-3761, a new quinolone derivative, in experimental animals…
Expand
1995
1995
[Absorption, distribution, excretion and metabolism of [14C] T-3761 in rats and mice].
H. Hayakawa
,
K. Hayashi
,
+4 authors
Y. Sogame
The Japanese Journal of Antibiotics
1995
Corpus ID: 38816294
Absorption, distribution, excretion and metabolism were studied in rats and mice after oral and intravenous administration of 5…
Expand
1995
1995
[Microbiological assay method for T-3761 concentration in body fluids].
J. Maehana
,
R. Kitayama
,
+5 authors
H. Narita
The Japanese Journal of Antibiotics
1995
Corpus ID: 42993604
A microbiological assay method for measurement of T-3761 and its stability in body fluids were investigated. The paper disc…
Expand
1995
1995
[Serum protein binding of T-3761].
R. Kitayama
,
T. Hayashi
,
S. Minami
,
Y. Watanabe
,
H. Narita
The Japanese Journal of Antibiotics
1995
Corpus ID: 8515971
We investigated the extent of the binding of T-3761 to serum protein and obtained the following results. 1. The binding rates of…
Expand
1993
1993
[In vitro antimycobacterial activity of a new quinolone, NM394].
H. Tomioka
,
K. Sato
,
H. Saito
Kekkaku : [Tuberculosis]
1993
Corpus ID: 29409324
We evaluated the in vitro antimicrobial activity of NM394 and ofloxacin (OFLX) against representative pathogenic mycobacteria by…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE